SI-BONE (SIBN) Financials: History & Chart

SI-BONE, Inc.(SIBN)

Medical - Devices · Santa Clara, CA

$19.55-0.26 (-1.31%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About SI-BONE, Inc.

SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.

Santa Clara, CA

376 employees

si-bone.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Laura A. Francis

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	213.60M	56.01M	52.59M	56.35M	48.66M	48.63M	47.29M	49.00M	40.34M
Cost of Goods Sold	43.73M	11.46M	10.64M	11.82M	9.81M	9.82M	9.60M	10.22M	8.44M
Gross Profit	169.87M	44.55M	41.94M	44.53M	38.85M	38.81M	37.70M	38.78M	31.90M
Gross Profit Margin	79.5%	79.5%	79.8%	79.0%	79.8%	79.8%	79.7%	79.1%	79.1%
Total Operating Expenses	187.61M	49.35M	47.04M	46.99M	44.23M	45.81M	45.17M	44.27M	39.54M
Research & Development	18.02M	5.22M	4.19M	4.36M	4.24M	4.31M	4.53M	3.87M	3.99M
Selling, General & Administrative	169.60M	44.13M	42.84M	42.63M	39.99M	41.50M	40.64M	40.40M	35.54M
Operating Income (EBIT)	-17.75M	-4.81M	-5.09M	-2.46M	-5.38M	-7.00M	-7.48M	-5.49M	-7.63M
Operating Margin	-8.3%	-8.6%	-9.7%	-4.4%	-11.1%	-14.4%	-15.8%	-11.2%	-18.9%
Income Before Tax (EBT)	-14.64M	-4.09M	-4.33M	-1.65M	-4.57M	-6.15M	-6.54M	-4.50M	-6.58M
Interest Income	5.64M	1.33M	1.35M	1.45M	1.51M	1.52M	1.59M	1.78M	1.94M
Interest Expense	2.49M	598K	592K	629K	670K	666K	662K	793K	884K
Other Income/Expense	3.11M	718K	759K	815K	817K	852K	938K	999K	1.06M
Net Income	-14.64M	-4.09M	-4.33M	-1.65M	-4.57M	-6.15M	-6.54M	-4.50M	-6.58M
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit Margin	-6.9%	-7.3%	-8.2%	-2.9%	-9.4%	-12.7%	-13.8%	-9.2%	-16.3%
EBITDA	-9.28M	-3.13M	-3.48M	1.22M	-3.90M	-5.64M	-6.20M	-4.28M	-6.55M
EBITDA Margin	-4.3%	-5.6%	-6.6%	2.2%	-8.0%	-11.6%	-13.1%	-8.7%	-16.2%
Depreciation & Amortization	8.46M	1.68M	1.62M	3.68M	1.49M	1.37M	1.28M	1.21M	1.08M
EPS Basic	-0.34	-0.09	-0.10	-0.04	-0.11	-0.14	-0.15	-0.11	-0.16
EPS Diluted	-0.34	-0.09	-0.10	-0.04	-0.11	-0.14	-0.15	-0.11	-0.16
Weighted Average Basic Shares	44.22M	44.22M	43.96M	43.51M	43.19M	42.79M	42.34M	41.99M	41.72M
Weighted Average Diluted Shares	44.22M	44.22M	43.96M	43.51M	43.19M	42.79M	42.34M	41.99M	41.72M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	200.93M	167.18M	138.89M	106.41M	90.15M	73.39M	67.30M	55.38M
Cost of Goods Sold	41.05M	35.06M	29.47M	15.71M	10.43M	8.90M	6.79M	4.83M
Gross Profit	159.88M	132.12M	109.42M	90.70M	79.72M	64.48M	60.51M	50.55M
Gross Profit Margin	79.6%	79.0%	78.8%	85.2%	88.4%	87.9%	89.9%	91.3%
Total Operating Expenses	182.21M	167.37M	156.35M	150.31M	131.39M	103.05M	96.51M	62.51M
Research & Development	17.45M	16.56M	15.03M	13.63M	12.44M	9.46M	7.28M	5.38M
Selling, General & Administrative	164.76M	150.81M	141.32M	136.69M	118.95M	93.59M	89.23M	57.14M
Operating Income (EBIT)	-22.33M	-35.25M	-46.93M	-59.61M	-51.67M	-38.57M	-36.00M	-11.96M
Operating Margin	-11.1%	-21.1%	-33.8%	-56.0%	-57.3%	-52.6%	-53.5%	-21.6%
Income Before Tax (EBT)	-18.91M	-30.91M	-43.34M	-61.26M	-56.57M	-43.70M	-38.40M	-17.45M
Interest Income	6.07M	7.85M	6.92M	1.30M	186K	1.10M	2.55M	769K
Interest Expense	5.28M	3.44M	3.46M	2.82M	5.37M	6.10M	4.95M	5.11M
Other Income/Expense	3.42M	4.33M	3.60M	-1.65M	-4.90M	-5.13M	-2.40M	-5.49M
Net Income	-18.91M	-30.91M	-43.34M	-61.26M	-56.57M	-43.70M	-38.40M	-17.45M
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit Margin	-9.4%	-18.5%	-31.2%	-57.6%	-62.8%	-59.5%	-57.1%	-31.5%
EBITDA	-19.61M	-30.87M	-41.50M	-56.16M	-49.58M	-37.44M	-35.23M	-11.24M
EBITDA Margin	-9.8%	-18.5%	-29.9%	-52.8%	-55.0%	-51.0%	-52.3%	-20.3%
Depreciation & Amortization	2.72M	4.38M	5.43M	3.45M	2.09M	1.13M	774K	722K
EPS Basic	-0.44	-0.75	-1.13	-1.79	-1.71	-1.50	-1.72	-1.10
EPS Diluted	-0.44	-0.75	-1.13	-1.79	-1.71	-1.50	-1.72	-1.10
Weighted Average Basic Shares	43.51M	41.47M	38.43M	34.20M	33.15M	29.06M	24.71M	15.90M
Weighted Average Diluted Shares	43.51M	41.47M	38.43M	34.20M	33.15M	29.06M	24.71M	15.90M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.